China Pharma Holdings, Inc. (CPHI) — DEF 14A Filings
All DEF 14A filings from China Pharma Holdings, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
CPHI Proposes 1:20 Reverse Stock Split, Boosts CEO Pay to $241,600
— Nov 14, 2025 Risk: high
China Pharma Holdings, Inc. (CPHI) is holding its Annual Meeting on December 30, 2025, to address critical corporate actions including the election of independe -
China Pharma Holdings Files 2024 Proxy Statement
— Nov 12, 2024 Risk: low
China Pharma Holdings, Inc. filed its Definitive Proxy Statement (DEF 14A) on November 12, 2024, for the fiscal year ending December 31, 2024. The filing concer
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX